Approval · Notice of Compliance 33732 · 2024
STEQEYMA: Notice of Compliance 33732
Issued July 30, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33732
- Date
- July 30, 2024
- Company
- Celltrion Inc.Incheon, Korea, Republic Of
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- STELARA / STELARA I.V
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STEQEYMA | 02550253 | Marketed |
| STEQEYMA | 02550245 | Marketed |
| STEQEYMA I.V. | 02550261 | Marketed |
Medicinal ingredients
- USTEKINUMAB 90 MG per ML
- USTEKINUMAB 45 MG per 0.5ML
- USTEKINUMAB 5 MG per ML